Thiazide use associated with lower bone turnover, higher bone mineral density and lower hip fracture risk in older Irish adults

Abstract Background Thiazide diuretics are associated with higher bone mineral density (BMD) and reduced risk of hip fracture. The mechanisms underlying this association remain incompletely understood but are thought to include reduced urinary calcium excretion and potential direct skeletal effects. We aimed to explore the association between thiazide use and bone turnover markers (BTM), BMD, and hip fracture in older Irish adults. Methods: Participants aged >60 years from the TUDA cohort of Irish adults. The relationship between thiazide use and hip fracture was examined using multinomial regression, adjusting for age, sex, BMI, vitamin D, PTH, timed up and go, diabetes, lifestyle factors, eGFR, and steroid use. In a subsample excluding individuals on osteoporosis medications, thiazide use and BTM as well as densitometrically measured BMD at the hip and lumbar spine were explored, adjusting for similar covariates. BTMsmeasured were serum TRAP5b (tartrate-resistant acid phosphatase 5b) and bone-specific alkaline phosphatase (BAP). Results In the overall sample (n=4451; mean age 73.4±8.1 years; 66.9% female), 23.5% were thiazide users and 234 participants reported a previous hip fracture. Thiazide use was associated with lower risk of hip fracture before and after multivariate adjustment (OR 0.62, 95% CI:0.41–0.95, p=0.0286). In a subsample (n=1839), thiazide users had significantly lower serum TRAP5b (2.64 vs 2.81 U/L, p<0.001), lower BAP (15.4 vs 17.3 μg/L, p<0.001), and higher BMD at both the hip (1.007 vs 0.994 g/cm2, p=0.04) and lumbar spine (1.222 vs 1.203 g/cm2, p=0.04). Conclusion: These findings support a beneficial effect of thiazides on BMD and hip fracture risk, potentially mediated through bone turnover suppression. Experimental data suggest thiazides may directly affect osteoclast function, although few studies have specifically examined effects on BTMs While thiazides may have protective skeletal effects, their potential to increase fall risk in older adults must be carefully considered in clinical practice.

Authors

Institutions

Publication Details

Journal
Age and Ageing
Published
2025-12-01
DOI
https://doi.org/10.1093/ageing/afaf318.016
Primary Topic
Bone health and osteoporosis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Thiazide use associated with lower bone turnover, higher bone mineral density and lower hip fracture risk in older Irish adults

Anne M. Molloy, Mary Ward, Éamon Laird, Catherine Hughes et al.
Age and Ageing
Bone health and osteoporosis research
article

Thiazide use associated with lower bone turnover, higher bone mineral density and lower hip fracture risk in older Irish adults

Anne M. Molloy, Mary Ward, Éamon Laird, Catherine Hughes, Kevin McCarroll, Dónal Fitzpatrick, JJ Strain, Rosaleen Lannon, Helene McNulty, Conal Cunningham, Leanne Hoey
article en

Abstract

Abstract Background Thiazide diuretics are associated with higher bone mineral density (BMD) and reduced risk of hip fracture. The mechanisms underlying this association remain incompletely understood but are thought to include reduced urinary calcium excretion and potential direct skeletal effects. We aimed to explore the association between thiazide use and bone turnover markers (BTM), BMD, and hip fracture in older Irish adults. Methods: Participants aged >60 years from the TUDA cohort of Irish adults. The relationship between thiazide use and hip fracture was examined using multinomial regression, adjusting for age, sex, BMI, vitamin D, PTH, timed up and go, diabetes, lifestyle factors, eGFR, and steroid use. In a subsample excluding individuals on osteoporosis medications, thiazide use and BTM as well as densitometrically measured BMD at the hip and lumbar spine were explored, adjusting for similar covariates. BTMsmeasured were serum TRAP5b (tartrate-resistant acid phosphatase 5b) and bone-specific alkaline phosphatase (BAP). Results In the overall sample (n=4451; mean age 73.4±8.1 years; 66.9% female), 23.5% were thiazide users and 234 participants reported a previous hip fracture. Thiazide use was associated with lower risk of hip fracture before and after multivariate adjustment (OR 0.62, 95% CI:0.41–0.95, p=0.0286). In a subsample (n=1839), thiazide users had significantly lower serum TRAP5b (2.64 vs 2.81 U/L, p<0.001), lower BAP (15.4 vs 17.3 μg/L, p<0.001), and higher BMD at both the hip (1.007 vs 0.994 g/cm2, p=0.04) and lumbar spine (1.222 vs 1.203 g/cm2, p=0.04). Conclusion: These findings support a beneficial effect of thiazides on BMD and hip fracture risk, potentially mediated through bone turnover suppression. Experimental data suggest thiazides may directly affect osteoclast function, although few studies have specifically examined effects on BTMs While thiazides may have protective skeletal effects, their potential to increase fall risk in older adults must be carefully considered in clinical practice.

Age and AgeingVol. 54(Supplement_4)
Mercer (Czechia) (CZ), University of Ulster (GB), Trinity College Dublin (IE), Geriatric Research Education and Clinical Center (US), Tokyo Metropolitan Geriatric Hospital (JP), Florida Atlantic University (US)
Openalex Percentile: Top 51%
Bone health and osteoporosis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.